1. Home
  2. CTXR vs HSCS Comparison

CTXR vs HSCS Comparison

Compare CTXR & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

SELL

Current Price

$0.51

Market Cap

13.4M

Sector

Health Care

ML Signal

SELL

Logo Heart Test Laboratories Inc.

HSCS

Heart Test Laboratories Inc.

HOLD

Current Price

$1.77

Market Cap

15.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTXR
HSCS
Founded
2007
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
15.8M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
CTXR
HSCS
Price
$0.51
$1.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 253.3K
75.5K
Earning Date
12-22-2026
12-14-2026
Dividend Yield
N/A
N/A
EPS Growth
43.38
★ 50.84
EPS
★ N/A
N/A
Revenue
N/A
★ $4,319.00
Revenue This Year
N/A
$295.93
Revenue Next Year
$104.18
$18,321.05
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.37
$1.63
52 Week High
$1.54
$5.25

Technical Indicators

Market Signals
Indicator
CTXR
HSCS
Relative Strength Index (RSI) 48.05 27.72
Support Level $0.47 N/A
Resistance Level $0.63 $2.18
Average True Range (ATR) 0.06 0.31
MACD -0.00 -0.06
Stochastic Oscillator 22.42 0.00

Price Performance

Historical Comparison
CTXR
HSCS

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.

Share on Social Networks: